FLCN and metabolic dysfunction-associated steatotic liver disease: Its loss resulted in the alleviation of NAFLD/NASH (e.g., reduced triglyceride accumulation, fibrosis, and inflammation) in Flcn knockout mice exposed to a NASH-inducing diet [143].